What is Betta Pharmaceuticals Co Revenue per Share?
Betta Pharmaceuticals Co's revenue per share for the
three
months ended in Mar. 2024 was ¥1.72.
Betta Pharmaceuticals Co's revenue per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥6.27.
Good Sign:
Betta Pharmaceuticals Co Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue Per Share Growth Rate of Betta Pharmaceuticals Co was 12.80% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 8.40% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 13.90% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 14.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Betta Pharmaceuticals Co's Revenue per Share or its related term are showing as below:
SZSE:300558'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.6 Med: 12.4 Max: 28.2
Current: 8.4
During the past 13 years, Betta Pharmaceuticals Co's highest 3-Year average Revenue Per Share Growth Rate was 28.20% per year. The lowest was 6.60% per year. And the median was 12.40% per year.
SZSE:300558's 3-Year Revenue Growth Rate is ranked better than 56.18% of 922
companies
in the Drug Manufacturers industry
Industry Median: 6.4
vs SZSE:300558: 8.40
Betta Pharmaceuticals Co Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Betta Pharmaceuticals Co's Revenue per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Betta Pharmaceuticals Co's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Betta Pharmaceuticals Co's PS Ratio falls into.
Betta Pharmaceuticals Co Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Betta Pharmaceuticals Co's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥6.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Betta Pharmaceuticals Co (SZSE:300558) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Betta Pharmaceuticals Co Revenue per Share Related Terms
Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Betta Pharmaceuticals Co (SZSE:300558) Business Description
Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300558 has been successfully added to your 